Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting
Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting
Active, not recruiting · NCT03831178 · Registry updated 2025-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2025-06-26 | NCT03831178 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AHS Cancer Control Alberta | 37 |
| Canadian Institutes of Health Research (CIHR) | 339 |
| University of Alberta | 249 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cross Cancer Institute | Edmonton | Canada | 146 |